Opportunity Information: Apply for RFA OH 26 001

The Centers for Disease Control and Prevention (CDC), through the National Institute for Occupational Safety and Health (NIOSH), is offering funding under a cooperative agreement mechanism to support research tied to the World Trade Center (WTC) Health Program. This opportunity focuses on generating practical, scientifically rigorous evidence that helps the program better understand and respond to health conditions linked to the September 11, 2001 terrorist attacks. The overall emphasis is on WTC-related physical and mental health conditions, particularly in areas where there is still uncertainty about how best to diagnose certain conditions or how to treat them effectively. NIOSH is also open to studying conditions that have emerged more recently, including those recognized after the treatment program began or after the WTC Health Program was formally established.

The main goals of the funding opportunity are to strengthen the WTC Health Program in ways that directly improve care and decision-making. Funded projects are expected to contribute to improved diagnosis and treatment activities within the program, expand what is known about the health effects of 9/11 exposures, answer high-priority questions about WTC-related health conditions, and translate lessons learned into better preparedness and response for future disasters. Because this is a cooperative agreement (U01), applicants should anticipate substantial program involvement from the funding agency compared with a standard research grant, with collaboration and coordination typically playing a bigger role in shaping and monitoring the work.

NIOSH is looking for a wide range of research types as long as they are clearly relevant to the WTC-exposed population and can meaningfully inform screening, clinical care, or public health practice. Proposed studies may include screening research to assess or improve methods for detecting disorders or health conditions, as well as diagnostic research that evaluates or develops improved approaches for identifying diseases or conditions where diagnostic clarity is lacking. Treatment research is encouraged, including studies that evaluate existing interventions, compare treatment approaches, or develop new and novel strategies when current care options remain uncertain. Prevention-focused projects are also eligible, particularly those that aim to prevent the onset, progression, or recurrence of disease, or that mitigate symptoms and complications over time.

The announcement also highlights several areas that broaden the scope beyond classic clinical trials. Quality of life research is explicitly included, reflecting the program’s interest in improving daily functioning, comfort, and overall well-being for individuals dealing with chronic illness, multiple conditions at once (multimorbidity), or long-term impacts of exposure. Omics research is another allowable category, including work on phenotypes, biomarkers, and genetic factors that may help predict disease risk or explain differences in disease development or treatment response. In addition, epidemiologic and clinical research is encouraged to identify patterns, causes, and risk factors among people exposed to 9/11-related hazards, while health services research can examine access to care, costs, and outcomes associated with how care is delivered within or alongside the WTC Health Program.

Implementation research is also in scope, aimed at understanding how evidence-based practices and research findings are shared, adopted, put into practice, maintained over time, and scaled in real-world clinical or program settings. Finally, the opportunity explicitly allows epidemiologic investigations into emerging conditions where early data suggest a possible connection to 9/11 exposure, even if the causal link is not yet confirmed. The CDC maintains examples of previously supported or received projects on its website, which can help applicants understand the types of studies that fit the program’s priorities.

Key administrative details include that this is a discretionary funding opportunity (CFDA 93.262) issued by CDC/NIOSH, with the funding opportunity number RFA OH 26 001 and a closing date of June 23, 2026. The award ceiling is listed as $550,000, and the agency expects to make about 30 awards. Eligibility is broad across U.S.-based entities and includes state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other eligible tribal organizations; public housing authorities/Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); small businesses; and other unrestricted eligible applicants as specified in the announcement. Foreign institutions are not eligible, and non-U.S. components of U.S. organizations are also not eligible, meaning the proposed work and the applicant organization’s eligible components must be domestic.

  • The Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Cooperative Research Agreements Related to the World Trade Center Health Program (U01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.262.
  • This funding opportunity was created on 2026-05-08.
  • Applicants must submit their applications by 2026-06-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $550,000.00 in funding.
  • The number of recipients for this funding is limited to 30 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Unrestricted.
Apply for RFA OH 26 001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This is a CDC funding opportunity issued through the National Institute for Occupational Safety and Health (NIOSH) to support research connected to the World Trade Center (WTC) Health Program. The focus is on producing practical, scientifically rigorous evidence that helps the program better understand, diagnose, and treat health conditions linked to the September 11, 2001 terrorist attacks.

What funding mechanism is being used?

The award uses a cooperative agreement mechanism (U01). Compared with a standard research grant, applicants should expect substantial involvement from the funding agency, including collaboration and coordination that may help shape and monitor the work.

Which agency is sponsoring this opportunity?

The sponsor is the Centers for Disease Control and Prevention (CDC), through NIOSH.

What is the funding opportunity number and CFDA listing?

The funding opportunity number is RFA OH 26 001. The CFDA listing provided is 93.262.

What is the application closing date?

The closing date listed in the announcement is June 23, 2026.

What is the maximum award amount (award ceiling)?

The award ceiling is listed as $550,000.

How many awards does the agency expect to make?

CDC/NIOSH expects to make about 30 awards.

What are the main goals of the funded research?

The goals described include strengthening the WTC Health Program in ways that directly improve care and decision-making by contributing to improved diagnosis and treatment activities, expanding knowledge about the health effects of 9/11 exposures, answering high-priority questions about WTC-related health conditions, and translating lessons learned into better preparedness and response for future disasters.

What health topics are emphasized?

The opportunity emphasizes WTC-related physical and mental health conditions, especially areas where there is uncertainty about the best ways to diagnose certain conditions or treat them effectively.

Are recently recognized or emerging conditions eligible research topics?

Yes. NIOSH indicates openness to studying conditions that have emerged more recently, including conditions recognized after the treatment program began or after the WTC Health Program was formally established.

Does the opportunity support research even when the causal link to 9/11 exposure is not yet confirmed?

Yes. The announcement explicitly allows epidemiologic investigations into emerging conditions where early data suggest a possible connection to 9/11 exposure, even if causality is not yet confirmed.

What types of research approaches are allowed?

A wide range of research types are acceptable as long as they are clearly relevant to the WTC-exposed population and can meaningfully inform screening, clinical care, or public health practice.

What is meant by screening research in this announcement?

Screening research may include studies that assess or improve methods for detecting disorders or health conditions in the WTC-exposed population.

What is meant by diagnostic research in this announcement?

Diagnostic research may include evaluating or developing improved approaches for identifying diseases or conditions where diagnostic clarity is lacking.

Is treatment research encouraged?

Yes. Treatment research is encouraged, including studies that evaluate existing interventions, compare treatment approaches, or develop new or novel strategies when current care options remain uncertain.

Are prevention-focused projects eligible?

Yes. Prevention-focused projects are eligible, particularly those aimed at preventing onset, progression, or recurrence of disease, or reducing symptoms and complications over time.

Does the opportunity include quality of life research?

Yes. Quality of life research is explicitly included, reflecting interest in improving daily functioning, comfort, and overall well-being for individuals dealing with chronic illness, multimorbidity, or long-term impacts of exposure.

Is omics research allowed under this opportunity?

Yes. Omics research is allowable, including work on phenotypes, biomarkers, and genetic factors that may help predict disease risk or explain differences in disease development or treatment response.

Are epidemiologic and clinical studies included?

Yes. Epidemiologic and clinical research is encouraged to identify patterns, causes, and risk factors among people exposed to 9/11-related hazards.

Is health services research within scope?

Yes. Health services research may examine access to care, costs, and outcomes associated with how care is delivered within or alongside the WTC Health Program.

What is implementation research in the context of this opportunity?

Implementation research is included and focuses on how evidence-based practices and research findings are shared, adopted, put into practice, maintained over time, and scaled in real-world clinical or program settings.

How should proposed projects connect to the WTC Health Program?

Funded projects are expected to generate evidence that strengthens the program and can inform screening, diagnosis, treatment, clinical care, and/or public health practice relevant to the WTC-exposed population.

Who is eligible to apply?

Eligibility is broad across U.S.-based entities and includes state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other eligible tribal organizations; public housing authorities/Indian housing authorities; nonprofits (501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); small businesses; and other unrestricted eligible applicants as specified in the announcement.

Are foreign institutions eligible to apply?

No. Foreign institutions are not eligible.

Are non-U.S. components of U.S. organizations eligible?

No. Non-U.S. components of U.S. organizations are not eligible. The applicant organization’s eligible components and the proposed work must be domestic.

Where can applicants find examples of the types of projects that fit the program?

The announcement notes that CDC maintains examples of previously supported or received projects on its website, which can help applicants understand the types of studies that fit the program’s priorities.

What does "discretionary" mean in this context?

The opportunity is described as a discretionary funding opportunity, meaning it is offered at the agency’s discretion under the cited program and is not an entitlement.

Browse more opportunities from the same agency: Centers for Disease Control and Prevention - ERA

Browse more opportunities from the same category: Health

Next opportunity: Specialty Crop Multi-State Grant Program 2026

Previous opportunity: FY2025 ABPP - Battlefield Restoration Grants

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA OH 26 001

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA OH 26 001) also looked into and applied for these:

Funding Opportunity
Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional) Apply for PAR 27 015

Funding Number: PAR 27 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional) Apply for RFA HD 27 012

Funding Number: RFA HD 27 012
Agency: National Institutes of Health
Category: Health
Funding Amount: $800,000
Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Apply for PAR 27 073

Funding Number: PAR 27 073
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed) Apply for RFA DE 27 001

Funding Number: RFA DE 27 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required) Apply for RFA CA 27 016

Funding Number: RFA CA 27 016
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed) Apply for RFA DE 27 002

Funding Number: RFA DE 27 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $4,000,000
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) Apply for PAR 27 077

Funding Number: PAR 27 077
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional) Apply for RFA DK 27 146

Funding Number: RFA DK 27 146
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required) Apply for RFA MH 27 135

Funding Number: RFA MH 27 135
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) Apply for RFA DC 27 004

Funding Number: RFA DC 27 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $700,000
Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) Apply for RFA HL 27 004

Funding Number: RFA HL 27 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $85,000
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 27 083

Funding Number: PAR 27 083
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed) Apply for PAR 27 075

Funding Number: PAR 27 075
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC) (U24 Clinical Trial Not Allowed) Apply for RFA MH 27 205

Funding Number: RFA MH 27 205
Agency: National Institutes of Health
Category: Health
Funding Amount: $5,000,000
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Apply for PAR 27 082

Funding Number: PAR 27 082
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed) Apply for RFA CA 27 017

Funding Number: RFA CA 27 017
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) Apply for RFA TS 26 165

Funding Number: RFA TS 26 165
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $500,000
Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence and Suicide Among Children and Youth (K01) Apply for RFA CE 26 021

Funding Number: RFA CE 26 021
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $150,000
Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities Apply for HHS 2026 IHS EP1 0001

Funding Number: HHS 2026 IHS EP1 0001
Agency: Indian Health Service
Category: Health
Funding Amount: $3,500,000
Community Health Aide Program: Tribal Planning and Implementation (TPI) Apply for HHS 2026 IHS TPI 0001

Funding Number: HHS 2026 IHS TPI 0001
Agency: Indian Health Service
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA OH 26 001", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: